Aligning Financial Management Systems to the Biotech Lifecycle: from Pre-Commercial to High Growth

Life sciences companies have increasingly complex businesses, and with this comes increasingly complex finances. Dynamic business drivers such as partnerships and alliances, joint ventures, and innovative R&D funding frameworks all combine to bring a new level of complexity to operations that directly impacts financial planning, reporting and compliance. Companies at all stages of lifecycle growth in the life sciences – from pre-commercial to established market contenders – are all seeking ways to mature their financial management processes. In this session featuring KPMG finance professionals, hear from experts on a range of topics:

• A framework designed for pre-commercial companies to enhance financial planning and budgeting, drawing in aspects of biopharma businesses such as grants, R&D expenses, employee costs, and G&A to produce an Excel-based workbook that supports enhanced reporting, analysis, and strategic planning.
• Discussion of how more mature life sciences companies are using digital technologies – including SAP S/4HANA – to transform the way they integrate operations and financial management to achieve new levels of business efficiency. The discussion will highlight case studies employing a leading practice target operating model designed specifically for high growth life sciences companies.

MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.